Skip to content

Hospitalized Children and Adolescent Patients With Type 1 Diabetes During the COVID-19 Pandemic in Egypt

Clinical Characteristics and Outcome of Hospitalized Children and Adolescent Patients With Type 1 Diabetes During the COVID-19 Pandemic: Data From a Single Center Surveillance Study in Egypt

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04536285
Enrollment
36
Registered
2020-09-02
Start date
2020-05-01
Completion date
2020-08-31
Last updated
2020-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, Type 1 Diabetes

Keywords

Type 1 Diabetes, Covid 19, Diabetic ketoacidosis

Brief summary

Although reports showed that children with well controlled diabetes do not appear to have increased risk of infection with SARS-CoV-2, however data are scarce regarding the extent to which clinical and demographic data of patient could modify the outcome and severity of the disease. Additionally, the link between covid-19 and diabetes remains controversial.

Detailed description

Data from poorly controlled patients with type 1 diabetes remains controversial regarding whether diabetes itself could increases the susceptibility of infection with SARS-CoV-2 and subsequently impacts the outcomes in these patients , or the SARS-CoV-2 subsequently affects the risk of type 1 diabetes and increase in the prevalence of severe DKA. Poorly controlled diabetes and chronic hyperglycemia creates a state of low grade chronic inflammation, which may explain the underlying mechanism of increased susceptibility to infection and infer the outcome in patients with diabetes . Poorly controlled diabetes has been linked to multiple derangements of immune system including inhibition of lymphocyte proliferation in response to different stimuli, as well as impaired monocyte/macrophage function together with increased synthesis of pro-inflammatory cytokines and adhesion molecules that mediate tissue inflammation . Few data links the association between development of diabetic ketoacidosis in patients with COVID-19, where the infection could trigger higher stressful conditions, with the release of stress hormones leading to increased blood glucose levels and abnormal glucose variability . The extent to which clinical and demographic data of patients with type 1 diabetes modifies the outcome and severity of the disease seems entirely unclear and is the question of several researches. • Study Tools: All patients admitted to Pediatrics Hospital, Ain Shams University in the period between May to August 2020 will be subjected to: 1- Detailed history 2. Thorough clinical examination: To assess the inclusion and exclusion criteria. A thorough clinical review to assess organ involvements and clinical and laboratory characteristics as well as the outcome measures in the studied cohort. 3\. Data collection: Demographic and data will be extracted from patients inpatient files and reports

Interventions

None listed

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
1 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* All patients with type 1 diabetes admitted to Pediatrics Hospital, Ain Shams University in the period between May to July 2020. * Age: less than 18 years old.

Exclusion criteria

• Children with other forms of diabetes, including: type 2, monogenic forms and secondary diabetes

Design outcomes

Primary

MeasureTime frameDescription
Clinical characteristic of pediatric and adolescent patients with type 1 diabetes hospitalized with COVID -19.4 monthscomplications and comorbidities associated with diabetes
Laboratory characteristic of pediatric and adolescent patients with type 1 diabetes hospitalized with COVID -19.4 monthsAcute phase reactants
Prognosis of pediatric and adolescent patients with type 1 diabetes hospitalized with COVID -19.4 monthIntensive care admission

Secondary

MeasureTime frameDescription
Incidence of new onset type 1 diabetes among confirmed cases of Covid-19 infection among children and adolescents4 monthsIncidence of new onset type 1 diabetes among confirmed cases of Covid-19 infection among children and adolescents
Presentation of diabetes and its acute complications among pediatric and adolescent patients with type 1 diabetes during COVID-19 Pandemic in Egypt4 monthImpact of Covid-19 pandemic on presentation of diabetes and its acute complications among pediatric and adolescent patients with type 1 diabetes

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026